Valuation: G MEDPAR

Market Cap 7L 6L 6L 5L 10.16L 6.97Cr 10.33L 70.04L 27.46L 3.41Cr 27.15L 26.56L 12Cr P/E 2021
-1.29x
P/E 2022 -0.17x
Enterprise Value 25.2L 22.09L 20.42L 18.78L 35.43L 24Cr 36L 2.44Cr 95.7L 12Cr 94.63L 92.56L 41Cr EV / Sales 2021
4.92x
EV / Sales 2022 1.15x
Free-Float
-
Yield 2021 *
-
Yield 2022 -
1 day+9,900.00%
Current year-50.00%
1 month 0
Extreme 0
0
Current year 0
Extreme 0
0
1 year 0
Extreme 0
0.03
3 years 0
Extreme 0
0.36
5 years 0
Extreme 0
235.9
10 years 0
Extreme 0
235.9
Manager TitleAgeSince
Chief Executive Officer 75 03/10/2014
Director of Finance/CFO 46 31/07/2022
Chief Tech/Sci/R&D Officer 56 01/12/2017
Director TitleAgeSince
Director/Board Member 75 03/10/2014
Chairman 72 21/08/2014
Director/Board Member 76 24/02/2017
Date Insider Type Main position Quantity % Market Cap.
31/03/23
AWM Investment Co., Inc.
OtherCompany 14,37,500 73.2011%
31/03/23
AWM Investment Co., Inc.
SellCompany 7,37,500 37.5554%

Financials

2021 2022
Net sales 50.58L 44.33L 40.98L 37.69L 71.11L 49Cr 72.25L 4.9Cr 1.92Cr 24Cr 1.9Cr 1.86Cr 82Cr 44.2L 38.74L 35.81L 32.94L 62.14L 43Cr 63.14L 4.28Cr 1.68Cr 21Cr 1.66Cr 1.62Cr 72Cr
Net income -1.48Cr -1.29Cr -1.2Cr -1.1Cr -2.07Cr -142.31Cr -2.11Cr -14Cr -5.6Cr -70Cr -5.54Cr -5.42Cr -239.9Cr -1.35Cr -1.19Cr -1.1Cr -1.01Cr -1.9Cr -130.38Cr -1.93Cr -13Cr -5.13Cr -64Cr -5.08Cr -4.97Cr -219.79Cr
Net Debt 24.08L 21.11L 19.51L 17.94L 33.86L 23Cr 34.4L 2.33Cr 91.45L 11Cr 90.42L 88.45L 39Cr 17.97L 15.75L 14.56L 13.39L 25.26L 17Cr 25.67L 1.74Cr 68.24L 8.48Cr 67.48L 66.01L 29Cr
Logo G MEDPAR
G Medical Innovations Holdings Ltd. is a mobile health (mHealth) and e-health company. The Company is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. It develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. It also develops wireless vital signs monitoring systems.
Employees
84
Sector
-
  1. Stock Market
  2. Stocks
  3. GMVDF Stock